3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is a single center study of patients with inactive or mild SLE being performed to determine the safety, tolerability, and pharmacodynamics of DIM.
Epistemonikos ID: 10880b12893033b2e7fb8958c1a8521d3b55511d
First added on: May 12, 2024